GENPHARMASEC
Quarterly Results Analysis [Dec2024]
GENPHARMASEC Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹8 Cr | ₹6 Cr | ₹5 Cr | ₹10 Cr | ₹6 Cr | ₹8 Cr | ₹0 Cr | ₹6 Cr |
Expenses | ₹8 Cr | ₹6 Cr | ₹5 Cr | ₹10 Cr | ₹6 Cr | ₹8 Cr | ₹0 Cr | ₹6 Cr |
Operating Income | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Other Income | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit Before Tax | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit After Tax | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
EPS | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.02 |
Industry Peers & Returns | 1W | 1M | 1Y |
GENPHARMASEC | -3.6% | -27.5% | -49.1% |
SUDARSHAN CHEMICAL INDUSTRIES | -7.1% | -22.3% | 50.7% |
KIRI INDUSTRIES | 4.5% | -1.1% | 40.8% |
VIDHI SPECIALTY FOOD INGREDIENTS | -1.4% | -15.6% | 7.3% |
SHREE PUSHKAR CHEMICALS & FERTILISERS | 11.7% | 19.9% | 71.9% |
BODAL CHEMICALS | -0.9% | -3.8% | -27.6% |
BHAGERIA INDUSTRIES | 1.6% | -2.4% | -1.7% |
DYNEMIC PRODUCTS | -4.6% | -17.3% | 3.6% |
PODDAR PIGMENTS | -4% | -12% | -18% |
GENPHARMASEC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 40.63 % |
Y-o-Y | 32.87 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹8 Cr | 40.63 | |
Sep2024 | ₹6 Cr | 16.13 | |
Jun2024 | ₹5 Cr | -49.06 | |
Mar2024 | ₹10 Cr | 59.73 | |
Dec2023 | ₹6 Cr | -18.76 | |
Sep2023 | ₹8 Cr | 0 | |
Jun2023 | ₹0 Cr | -100.00 | |
Mar2023 | ₹6 Cr | - |
GENPHARMASEC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 475.00 % |
Y-o-Y | 4,229.41 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹1 Cr | 475.00 | |
Sep2024 | ₹0 Cr | -28.09 | |
Jun2024 | ₹0 Cr | Positive | |
Mar2024 | ₹0 Cr | Negative | |
Dec2023 | ₹0 Cr | Positive | |
Sep2023 | ₹0 Cr | 0 | |
Jun2023 | ₹0 Cr | -100.00 | |
Mar2023 | ₹0 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 309.43 % |
Y-o-Y | 3,114.81 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 8.68% | 309.43 | |
Sep2024 | 2.12% | -38.19 | |
Jun2024 | 3.43% | Positive | |
Mar2024 | -0.13% | Negative | |
Dec2023 | 0.27% | Positive | |
Sep2023 | -0.53% | 0 | |
Jun2023 | 0% | -100.00 | |
Mar2023 | 3.33% | - |
GENPHARMASEC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 10.80 % |
Y-o-Y | 1,138.10 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹1 Cr | 10.80 | |
Sep2024 | ₹1 Cr | 145.30 | |
Jun2024 | ₹0 Cr | Positive | |
Mar2024 | ₹0 Cr | Negative | |
Dec2023 | ₹0 Cr | 950.00 | |
Sep2023 | ₹0 Cr | 0 | |
Jun2023 | ₹0 Cr | -100.00 | |
Mar2023 | ₹1 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -21.25 % |
Y-o-Y | 828.28 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 9.19 % | -21.25 | |
Sep2024 | 11.67 % | 111.41 | |
Jun2024 | 5.52 % | Positive | |
Mar2024 | -2.62 % | Negative | |
Dec2023 | 0.99 % | 1,137.50 | |
Sep2023 | 0.08 % | 0 | |
Jun2023 | 0 % | -100.00 | |
Mar2023 | 16.83 % | - |
GENPHARMASEC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 0.00 % |
Y-o-Y | 0 |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹0.01 | 0.00 | |
Sep2024 | ₹0.01 | 0.00 | |
Jun2024 | ₹0.01 | 0 | |
Mar2024 | ₹0 | 0 | |
Dec2023 | ₹0 | 0 | |
Sep2023 | ₹0 | 0 | |
Jun2023 | ₹0 | -100.00 | |
Mar2023 | ₹0.02 | - |
You may also like the below Video Courses